On December 18, the U.S. Consumer Product Safety Commission announced two separate recalls involving products that violated the Poison Prevention Packaging Act. According to the agency, the packaging on both products was not child-resistant, creating what it described as a risk of serious injury or death from poisoning if the contents are swallowed by children.
Mamisan Pain-Relieving Topical Ointment Recall
One recall involves Mamisan Pain Relieving Topical Ointment, a product manufactured by Florida-based MiramarLab and distributed by California-based Plantimex. The ointment was sold in 3.52-ounce jars for approximately $10 at major retailers, including Walmart and Target, as well as through online channels nationwide.
The recalled ointment contains lidocaine, a commonly used anesthetic in topical pain relief products. Under the Poison Prevention Packaging Act, products containing lidocaine are required to be sold in child-resistant packaging. The Consumer Product Safety Commission determined that the packaging for this product did not meet those standards.
Only jars with UPC 860006498115 are included in the recall. According to the agency, the affected products were sold between April 2024 and October 2025. At the time of the announcement, no injuries or incidents had been reported in connection with the product.
The Consumer Product Safety Commission instructed consumers to immediately secure the recalled jars out of the sight and reach of children. Additionally, purchasers are advised to contact Plantimex to obtain a free replacement lid. Once the child-resistant lid has been installed, consumers may continue using the ointment as intended.
Feel The Beard Minoxidil Oil Recall
In a separate announcement, the Consumer Product Safety Commission recalled Feel The Beard Minoxidil Beard Growth Oil for Men. The product, which is manufactured in China, was also found to violate the Poison Prevention Packaging Act due to the absence of child-resistant packaging.
The beard oil contains minoxidil, a substance commonly used in topical treatments for pattern hair loss. In some cases, minoxidil is also prescribed orally to treat severe high blood pressure. The Consumer Product Safety Commission noted that ingestion of topical minoxidil can cause severe drops in blood pressure.
Approximately 840 units of the recalled product were sold on Amazon.com between April 2025 and September 2025 for about $10. As with the Mamisan product, no injuries have been reported.
Consumers who purchased the recalled bottles are instructed to immediately secure them and keep them out of reach of children. The Consumer Product Safety Commission directed purchasers to contact Feel The Beard for instructions on properly destroying the recalled bottles. The agency stated that the contents may be poured into a trash can, after which consumers can receive a replacement product.
Regulatory Context and Broader Enforcement
The Poison Prevention Packaging Act was enacted in 1970 and requires certain household substances to be sold in packaging that is significantly difficult for children under five years of age to open within a reasonable period of time, while remaining accessible for adult use. The Consumer Product Safety Commission oversees enforcement of these standards.
According to the agency, these recalls are part of a broader pattern of enforcement activity. Other products recalled this year for similar violations include iron vitamin supplements and Benadryl.
Stay informed and ahead of the curve — explore more industry insights and program opportunities at ProgramBusiness.com.